GLP-1 Weight Loss in Port St. Lucie, FL: A City of 258,575 With Zero Clinics Publishing a Price
Port St. Lucie's obesity rate against Florida's, Florida Medicaid's narrow Saxenda-only carve-out, a zero-result local price search, and population-based HPSA designations.
30.5% of Port St. Lucie adults have obesity (CDC PLACES 2025 release, city-level, BRFSS 2023) 1, just above Florida's 30.1% state total for the same year 3, with St. Lucie County tracked separately in the same release 2. This is one of the narrower city-versus-state gaps in the pack.
It is also a comparatively well-off, well-insured city: 258,575 residents inside a 556,336-person metro, median household income $86,241, 9.9% uninsured 45910. None of that produces a single in-city clinic willing to publish a GLP-1 price.
St. Lucie County (all of Port St. Lucie sits inside it) carries three active HRSA Health Professional Shortage Area designations, all population-based rather than geographic-wide: Primary Care - 'LI/MFW - St. Lucie County,' score 11, Designated, 56,651 estimated underserved of a 106,321 designation population; Dental Health - same population base, score 11, Designated, 93,230 underserved; Mental Health - two overlapping designations, 'LI-SE FL Behavioral Health-Circuit 19-MHCA' (multi-county, FL's 19th Judicial Circuit), score 16, Designated, 140,755 underserved, plus a county-only designation at score 17 currently Proposed For Withdrawal. All are targeted at low-income/migrant-farmworker populations; HRSA classifies the county Non-Rural, so this is a specific-population access gap, not a blanket county-wide shortage. Source: HRSA BCD_HPSA_FCT_DET (Primary Care/Mental Health/Dental Health downloads), data.hrsa.gov, checked 2026-08-28.678
Specialist access
No fellowship-trained endocrinology or obesity-medicine practice publishing self-pay pricing was found physically located in Port St. Lucie: a four-term BBB search (weight loss clinic, semaglutide, medical spa, GLP-1 weight loss) plus an OpenStreetMap POI check of the city's official boundary both returned zero in-city matches (checked 2026-08-28). Two hospital systems ARE physically in-city - Cleveland Clinic Martin Health's Tradition Hospital (10000 SW Innovation Way) and HCA Florida St. Lucie Hospital/Saint Lucie Medical Center (1800 SE Tiffany Ave) - but neither hospital's public location page lists an endocrinology, bariatric, or weight-management program with published pricing. Combined with the population-based (not geography-wide) HPSA designations above, GLP-1 specialist access in Port St. Lucie appears to run through primary care and telehealth rather than a dedicated in-city obesity-medicine clinic. No physician-headcount dataset (e.g., HRSA's Area Health Resources File) was consulted this pass - treat as a documented data gap, not a confirmed shortage statistic.1516
Medicaid coverage note
Florida has not adopted ACA Medicaid expansion (Not adopted, KFF Status of State Medicaid Expansion Decisions, checked 2026-08-28) - low-income childless adults largely fall into the coverage gap rather than qualifying for Medicaid, part of why cash-pay/telehealth is the default access path for GLP-1s in this market. On the drugs themselves: KFF's Medicaid Coverage of and Spending on GLP-1s brief categorizes Florida FFS Medicaid as Not covered for the obesity indication (only 13 state Medicaid programs covered obesity-indication GLP-1s as of Jan 2026, Florida not among them). But Florida's own AHCA Medicaid drug-limitations list (updated 07/31/2026) carves out Saxenda (liraglutide) - the one GLP-1 product FDA-approved solely for chronic weight management - as covered with a minimum age of 12, while Wegovy and Zepbound, the newer obesity-indication semaglutide/tirzepatide brands, do not appear in that document at all. Treat Florida Medicaid's GLP-1 coverage as narrow and product-specific rather than a blanket no.111213
Florida's coverage is narrow and product-specific, not a blanket no
Florida has not adopted ACA Medicaid expansion ("Not adopted," KFF Status of State Medicaid Expansion Decisions, checked 2026-08-28) 11, so low-income childless adults largely fall into the coverage gap rather than qualifying for Medicaid, part of why cash-pay telehealth is the default access path for GLP-1s in this market.
On the drugs themselves, KFF's Medicaid Coverage of and Spending on GLP-1s brief categorizes Florida FFS Medicaid as Not covered for the obesity indication; only 13 state Medicaid programs covered obesity-indication GLP-1s as of Jan 2026, and Florida is not among them 12. But Florida's own AHCA Medicaid drug-limitations list (updated 07/31/2026) carves out Saxenda (liraglutide), the one GLP-1 product FDA-approved solely for chronic weight management, as covered with a minimum age of 12, while Wegovy and Zepbound do not appear in that document at all 13. Treat Florida Medicaid's GLP-1 coverage as narrow and product-specific rather than a blanket no.
What GLP-1 care costs in Port St. Lucie today
A four-term BBB search (weight loss clinic, semaglutide, medical spa, GLP-1 weight loss) targeted at Port St. Lucie returned zero results with an address inside city limits across all four searches, independently re-run and confirmed. The nearest matches are The Oasis Medspa Incorporated in Stuart (zip 34997, about 18 miles south) and Delmar Aesthetics LLC in Palm City (zip 34990, about 15 miles south); neither is inside the city. The "GLP-1 weight loss" search term returned zero listings anywhere near the city 14.
An OpenStreetMap POI check of the city's official boundary surfaced exactly one weight-loss-adjacent business address inside city limits, Elevate Men America at 266 NW Peacock Blvd, a men's health and TRT clinic. Its own domain now 301-redirects to an unrelated spam/blog page, and independent re-verification via Bing, Florida's Sunbiz corporate registry, and Yelp could not confirm the business exists at all. It is flagged for re-verification and is not usable as a current provider or price source.
Two hospital systems are confirmed physically in-city, Cleveland Clinic Martin Health's Tradition Hospital at 10000 SW Innovation Way and HCA Florida St. Lucie Hospital / Saint Lucie Medical Center at 1800 SE Tiffany Ave, but neither publishes an endocrinology, bariatric, or medical-weight-management program page with self-pay GLP-1 pricing 1516.
Astra's price is $68/mo semaglutide and $118/mo tirzepatide, both 12-month plans at $816 and $1,416 billed annually. It is the flat national price, identical in Port St. Lucie to every other city.
Shortage designations aimed at specific populations, not the whole county
St. Lucie County, which contains all of Port St. Lucie, carries three active HRSA designations, all population-based rather than geographic-wide: Primary Care, "LI/MFW - St. Lucie County," score 11, Designated, 56,651 estimated underserved of a 106,321 designation population; Dental Health on the same population base, score 11, Designated, 93,230 underserved; and Mental Health through two overlapping designations, "LI-SE FL Behavioral Health-Circuit 19-MHCA" (multi-county, Florida's 19th Judicial Circuit), score 16, Designated, 140,755 underserved, plus a county-only designation at score 17 currently Proposed For Withdrawal. All are targeted at low-income and migrant-farmworker populations, and HRSA classifies the county Non-Rural, so this is a specific-population access gap, not a blanket county-wide shortage (HRSA BCD downloads, checked 2026-08-28) 678.
No fellowship-trained endocrinology or obesity-medicine practice publishing self-pay pricing was found physically located in Port St. Lucie. Combined with the population-based designations above, GLP-1 specialist access here appears to run through primary care and telehealth rather than a dedicated in-city obesity-medicine clinic. No physician-headcount dataset such as HRSA's Area Health Resources File was consulted this pass, so treat that as a documented data gap, not a confirmed shortage statistic.
For a city with no in-city clinic publishing a price, telehealth is the only route to a number you can see before you book. See the Florida GLP-1 overview for statewide context.
Astra treats patients in Florida through state-licensed physicians.
Local options
BBB business search - 4 category terms (weight loss clinic, semaglutide, medical spa, GLP-1 weight loss) targeted at Port St. Lucie, FL — Zero results with an address inside Port St. Lucie city limits across all four searches, independently re-run and confirmed. Nearest matches to the city are The Oasis Medspa Incorporated (zip 34997, Stuart, FL - about 18 mi south) and Delmar Aesthetics LLC (zip 34990, Palm City, FL - about 15 mi south); neither is inside the city so neither qualifies as a local Port St. Lucie clinic. The GLP-1 weight loss search term returned zero listings anywhere near the city. https://www.bbb.org/search?find_country=USA&find_text=weight+loss+clinic&find_loc=Port+St.+Lucie%2C+FL(checked 2026-08-28)
Elevate Men America (address on file: 266 NW Peacock Blvd, Port St. Lucie, FL - men's health/TRT clinic) — The only weight-loss-adjacent business address found inside city limits via OpenStreetMap POI data. Its own domain now 301-redirects to an unrelated spam/blog page, and independent re-verification (Bing via WebFetch, Florida's Sunbiz corporate registry, Yelp) could not confirm this business exists at all - each check either found nothing or was blocked. Flagged for re-verification (name, address, current operating status) before any future citation; no live pricing exists to cite and this should not be used as a current provider. https://elevatemenamerica.com/(checked 2026-08-28)
Cleveland Clinic Martin Health - Tradition Hospital (10000 SW Innovation Way, Port St. Lucie) and HCA Florida St. Lucie Hospital / Saint Lucie Medical Center (1800 SE Tiffany Ave, Port St. Lucie) — Both hospital systems are confirmed physically located inside the city (verified via OpenStreetMap and each system's own location page), but neither publishes an endocrinology, bariatric, or medical-weight-management program page with self-pay GLP-1 pricing. https://www.hcafloridahealthcare.com/locations/st-lucie-hospital(checked 2026-08-28)
Frequently asked questions
Is Astra cheaper than local GLP-1 options in Port St. Lucie?
There is no local price to compare against: a BBB search across four clinic categories plus an OpenStreetMap check of Port St. Lucie's city limits found zero weight-loss clinics, medical spas, or GLP-1 providers physically in the city that publish self-pay pricing (checked 2026-08-28). Astra's price is national and flat - $68/mo for semaglutide, $118/mo for tirzepatide, both on 12-month plans ($816/$1,416 billed annually) - the same in Port St. Lucie as anywhere else Astra serves.
Are there any local weight-loss or GLP-1 clinics in Port St. Lucie that publish their prices?
None found. A four-term BBB business search (weight loss clinic, semaglutide, medical spa, GLP-1 weight loss) plus an OpenStreetMap sweep of the city's official boundary turned up zero dedicated weight-loss or med-spa storefronts inside Port St. Lucie with published GLP-1 pricing. The two hospital systems physically in the city - Cleveland Clinic Martin Health's Tradition Hospital and HCA Florida St. Lucie Hospital - don't publish weight-management cash pricing either. The nearest medical spas identified (Oasis Medspa, Delmar Aesthetics) sit roughly 15-18 miles south, outside city limits.
How does Port St. Lucie's obesity rate compare with the rest of Florida?
Port St. Lucie's adult obesity rate is 30.5% (crude prevalence, 2023 BRFSS via CDC PLACES), just above Florida's statewide rate of 30.1% (2023 BRFSS). St. Lucie County as a whole runs slightly hotter, at 31.5%, reflecting Fort Pierce and unincorporated areas outside city limits - the city figure itself tracks close to the state average.
Is Port St. Lucie considered a health professional shortage area (HPSA)?
St. Lucie County carries three active HRSA shortage designations covering primary care, dental health, and mental health - all targeted at low-income and migrant-farmworker populations rather than the whole county, and HRSA classifies the county as non-rural. There is no HRSA category specific to endocrinology or obesity medicine, so this points to constrained access for underserved groups rather than a blanket citywide shortage.
Does Florida Medicaid cover GLP-1 weight-loss medications like Ozempic or Wegovy?
Mostly no. Florida has not adopted Medicaid expansion, and KFF's tracker lists Florida Medicaid as not covering GLP-1s for the obesity indication generally. But Florida's own Medicaid drug-limitations list does cover Saxenda (liraglutide), the one GLP-1 approved solely for weight management, for patients 12 and up - while the newer obesity brands Wegovy and Zepbound aren't listed at all. Ozempic and Mounjaro are covered only under their diabetes indication, with age and quantity limits.